Concepts (146)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Cholelithiasis | 1 | 2018 | 47 | 0.72 | Why? |
| Ultrasonography | 6 | 2021 | 4409 | 0.69 | Why? |
| Internal Medicine | 2 | 2020 | 557 | 0.65 | Why? |
| Ventricular Function, Right | 1 | 2020 | 388 | 0.64 | Why? |
| Point-of-Care Systems | 3 | 2018 | 2955 | 0.59 | Why? |
| Echocardiography | 3 | 2021 | 3661 | 0.59 | Why? |
| Heart Ventricles | 1 | 2020 | 1139 | 0.44 | Why? |
| Tuberculosis, Pulmonary | 1 | 2019 | 1171 | 0.37 | Why? |
| Ventricular Dysfunction, Left | 1 | 2017 | 993 | 0.36 | Why? |
| Cardiomyopathies | 1 | 2017 | 997 | 0.33 | Why? |
| Autonomic Nervous System | 2 | 2017 | 148 | 0.30 | Why? |
| Ultrasonic Therapy | 1 | 2020 | 43 | 0.21 | Why? |
| Cardiovascular System | 2 | 2018 | 750 | 0.20 | Why? |
| Endothelial Progenitor Cells | 1 | 2020 | 103 | 0.19 | Why? |
| Lung | 6 | 2021 | 31049 | 0.18 | Why? |
| Hypoalbuminemia | 1 | 2021 | 235 | 0.18 | Why? |
| Myotonic Dystrophy | 1 | 2017 | 51 | 0.17 | Why? |
| Angioedemas, Hereditary | 1 | 2017 | 55 | 0.17 | Why? |
| Systole | 1 | 2017 | 252 | 0.15 | Why? |
| Chagas Disease | 1 | 2018 | 155 | 0.15 | Why? |
| Emergency Service, Hospital | 1 | 2020 | 14232 | 0.14 | Why? |
| Models, Organizational | 1 | 2020 | 908 | 0.13 | Why? |
| Secondary Prevention | 1 | 2019 | 762 | 0.13 | Why? |
| Lower Extremity | 1 | 2019 | 593 | 0.13 | Why? |
| Italy | 8 | 2021 | 38444 | 0.13 | Why? |
| Physical Examination | 1 | 2018 | 755 | 0.12 | Why? |
| Flow Cytometry | 1 | 2020 | 2393 | 0.11 | Why? |
| Education, Medical, Continuing | 1 | 2018 | 638 | 0.11 | Why? |
| Infection Control | 1 | 2020 | 23131 | 0.11 | Why? |
| Prospective Studies | 6 | 2021 | 43301 | 0.11 | Why? |
| Apoptosis | 1 | 2020 | 2335 | 0.10 | Why? |
| Pneumonia, Viral | 5 | 2021 | 243684 | 0.10 | Why? |
| Sleep Apnea, Obstructive | 1 | 2017 | 668 | 0.09 | Why? |
| Emigrants and Immigrants | 1 | 2018 | 888 | 0.09 | Why? |
| Teaching | 1 | 2018 | 1208 | 0.09 | Why? |
| Sensitivity and Specificity | 3 | 2019 | 22971 | 0.09 | Why? |
| Multivariate Analysis | 1 | 2019 | 5440 | 0.09 | Why? |
| Interferon-gamma | 1 | 2018 | 2711 | 0.09 | Why? |
| Pilot Projects | 1 | 2019 | 5182 | 0.08 | Why? |
| Humans | 24 | 2021 | 930598 | 0.08 | Why? |
| Oxygen | 1 | 2020 | 3715 | 0.08 | Why? |
| Prognosis | 2 | 2021 | 32490 | 0.08 | Why? |
| Hospitals, University | 1 | 2019 | 4173 | 0.08 | Why? |
| Lopinavir | 1 | 2020 | 4308 | 0.08 | Why? |
| Patient Care Team | 1 | 2020 | 3556 | 0.08 | Why? |
| Ritonavir | 1 | 2020 | 4212 | 0.07 | Why? |
| Particulate Matter | 1 | 2018 | 3249 | 0.07 | Why? |
| Polymerase Chain Reaction | 1 | 2020 | 6740 | 0.07 | Why? |
| Hospitalization | 3 | 2021 | 54280 | 0.07 | Why? |
| Middle Aged | 12 | 2021 | 270681 | 0.07 | Why? |
| Risk Factors | 7 | 2021 | 71621 | 0.07 | Why? |
| Heart Rate | 3 | 2018 | 1527 | 0.07 | Why? |
| Logistic Models | 1 | 2019 | 9089 | 0.07 | Why? |
| Male | 14 | 2021 | 367725 | 0.06 | Why? |
| Venous Thrombosis | 1 | 2019 | 2739 | 0.06 | Why? |
| Venous Thromboembolism | 1 | 2021 | 4273 | 0.06 | Why? |
| Pulmonary Embolism | 1 | 2021 | 4775 | 0.06 | Why? |
| Gated Blood-Pool Imaging | 1 | 2000 | 3 | 0.06 | Why? |
| Reproducibility of Results | 1 | 2018 | 11304 | 0.06 | Why? |
| CD146 Antigen | 1 | 2020 | 19 | 0.06 | Why? |
| Ultrasonic Waves | 1 | 2020 | 32 | 0.06 | Why? |
| Dobutamine | 1 | 2000 | 36 | 0.05 | Why? |
| Air Pollutants | 1 | 2018 | 3110 | 0.05 | Why? |
| Models, Cardiovascular | 1 | 2021 | 153 | 0.05 | Why? |
| Risk Assessment | 2 | 2021 | 25439 | 0.05 | Why? |
| Female | 13 | 2021 | 380317 | 0.05 | Why? |
| Partial Pressure | 1 | 2020 | 279 | 0.05 | Why? |
| Capillary Leak Syndrome | 1 | 2021 | 119 | 0.05 | Why? |
| El Salvador | 1 | 2018 | 27 | 0.05 | Why? |
| Ultrasonography, Doppler, Color | 1 | 2019 | 107 | 0.05 | Why? |
| Drug Tolerance | 1 | 2018 | 100 | 0.04 | Why? |
| Nitroimidazoles | 1 | 2018 | 69 | 0.04 | Why? |
| Bolivia | 1 | 2018 | 187 | 0.04 | Why? |
| Sleep Stages | 1 | 2017 | 52 | 0.04 | Why? |
| Aged | 9 | 2021 | 215776 | 0.04 | Why? |
| Vagus Nerve | 1 | 2017 | 57 | 0.04 | Why? |
| Adult | 6 | 2021 | 244371 | 0.04 | Why? |
| Cardiotonic Agents | 1 | 2000 | 418 | 0.04 | Why? |
| Coronavirus Infections | 3 | 2020 | 253789 | 0.04 | Why? |
| Internship and Residency | 1 | 2018 | 4987 | 0.04 | Why? |
| Trypanosoma cruzi | 1 | 2018 | 133 | 0.04 | Why? |
| Pandemics | 4 | 2020 | 389249 | 0.04 | Why? |
| Methylation | 1 | 2018 | 332 | 0.04 | Why? |
| Predictive Value of Tests | 3 | 2021 | 9537 | 0.04 | Why? |
| Blood Gas Analysis | 1 | 2020 | 893 | 0.04 | Why? |
| Severe Acute Respiratory Syndrome | 1 | 2020 | 12361 | 0.04 | Why? |
| Hydroxychloroquine | 1 | 2020 | 12447 | 0.04 | Why? |
| Hospital Mortality | 1 | 2020 | 22087 | 0.04 | Why? |
| Polysomnography | 1 | 2017 | 296 | 0.04 | Why? |
| Severity of Illness Index | 2 | 2020 | 48226 | 0.04 | Why? |
| Interleukin-8 | 1 | 2021 | 964 | 0.04 | Why? |
| Cross-Over Studies | 1 | 2018 | 867 | 0.03 | Why? |
| Coronary Disease | 1 | 2000 | 645 | 0.03 | Why? |
| Coronary Artery Bypass | 1 | 2000 | 629 | 0.03 | Why? |
| Interleukin-10 | 1 | 2021 | 1409 | 0.03 | Why? |
| Inhalation Exposure | 1 | 2018 | 405 | 0.03 | Why? |
| Hemodynamics | 1 | 2021 | 1562 | 0.03 | Why? |
| Particle Size | 1 | 2018 | 1052 | 0.03 | Why? |
| RNA, Viral | 1 | 2020 | 32276 | 0.03 | Why? |
| Data Accuracy | 1 | 2018 | 715 | 0.03 | Why? |
| Latin America | 1 | 2018 | 1721 | 0.03 | Why? |
| Kinetics | 1 | 2020 | 3238 | 0.03 | Why? |
| Healthy Volunteers | 1 | 2018 | 1444 | 0.03 | Why? |
| Respiratory Mucosa | 1 | 2021 | 1522 | 0.03 | Why? |
| Bronchoalveolar Lavage Fluid | 1 | 2021 | 2309 | 0.03 | Why? |
| Ventricular Function, Left | 1 | 2000 | 1555 | 0.03 | Why? |
| Heart | 1 | 2021 | 1791 | 0.03 | Why? |
| Computed Tomography Angiography | 1 | 2021 | 2153 | 0.03 | Why? |
| Drug Combinations | 1 | 2020 | 3852 | 0.03 | Why? |
| Case-Control Studies | 2 | 2020 | 17671 | 0.03 | Why? |
| Endothelium, Vascular | 1 | 2021 | 1751 | 0.02 | Why? |
| ROC Curve | 1 | 2021 | 6024 | 0.02 | Why? |
| Young Adult | 1 | 2019 | 93724 | 0.02 | Why? |
| Betacoronavirus | 3 | 2020 | 204454 | 0.02 | Why? |
| Antiviral Agents | 1 | 2020 | 41703 | 0.02 | Why? |
| Survival Rate | 1 | 2021 | 9206 | 0.02 | Why? |
| Blood Pressure | 1 | 2017 | 2198 | 0.02 | Why? |
| Acute Disease | 1 | 2019 | 6029 | 0.02 | Why? |
| Hypoxia | 1 | 2020 | 3626 | 0.02 | Why? |
| Internationality | 1 | 2018 | 3297 | 0.02 | Why? |
| Intubation, Intratracheal | 1 | 2021 | 3962 | 0.02 | Why? |
| Retrospective Studies | 3 | 2021 | 105322 | 0.02 | Why? |
| Electrocardiography | 1 | 2017 | 3957 | 0.02 | Why? |
| Enzyme-Linked Immunosorbent Assay | 1 | 2018 | 7868 | 0.01 | Why? |
| Immunoassay | 1 | 2018 | 4485 | 0.01 | Why? |
| Length of Stay | 1 | 2019 | 11042 | 0.01 | Why? |
| Hospitals | 1 | 2020 | 11793 | 0.01 | Why? |
| Host-Pathogen Interactions | 1 | 2020 | 11041 | 0.01 | Why? |
| Follow-Up Studies | 1 | 2019 | 17020 | 0.01 | Why? |
| Viral Load | 1 | 2020 | 15850 | 0.01 | Why? |
| Aged, 80 and over | 2 | 2020 | 88759 | 0.01 | Why? |
| Respiratory Insufficiency | 1 | 2020 | 7301 | 0.01 | Why? |
| Age Factors | 1 | 2020 | 21039 | 0.01 | Why? |
| Postoperative Period | 1 | 2000 | 651 | 0.01 | Why? |
| Anticoagulants | 1 | 2019 | 9563 | 0.01 | Why? |
| Chi-Square Distribution | 1 | 2000 | 961 | 0.01 | Why? |
| Biomarkers | 1 | 2020 | 23361 | 0.01 | Why? |
| Incidence | 1 | 2019 | 25622 | 0.01 | Why? |
| Infusions, Intravenous | 1 | 2000 | 1224 | 0.01 | Why? |
| Prevalence | 1 | 2018 | 25773 | 0.01 | Why? |
| Respiration, Artificial | 1 | 2021 | 22116 | 0.01 | Why? |
| Intensive Care Units | 1 | 2020 | 29594 | 0.01 | Why? |
| Surveys and Questionnaires | 1 | 2018 | 43792 | 0.01 | Why? |
| Cross-Sectional Studies | 1 | 2018 | 53120 | 0.01 | Why? |
| Child | 1 | 2018 | 70012 | 0.01 | Why? |
| Adolescent | 1 | 2018 | 86841 | 0.01 | Why? |
Cogliati's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(146)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(168)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_